KORTUC
Developer of a novel radiosensitizer designed to enhance the efficacy of cancer radiotherapy. The company develops hydrogen peroxide-based drugs delivered via a prefilled syringe, injected intratumora...
Valuation
$0
Share Price
N/A
Total Raised
$44.4M
Last Round
N/A